title: [Polyalkylimide filler in human immunodeficiency virus-associated facial lipodystrophy: ophthalmic complications].
abstract: METHODS
  A 54 year old male, who consulted for acute inflammatory palpebral edema. The patient has HIV infection (on antiretroviral treatment) and an associated facial lipodystrophy that was filled with polyalkylimide in both frontotemporal regions one year before. MRI revealed subcutaneous abscesses in the filled areas, which led to preseptal cellulitis. Complete remission was achieved with antibiotic therapy and monitoring.
  
  
  CONCLUSIONS
  Polyalkylimide is a hydrogel that is recently used as facial filler without FDA approval. Although it was believed to be safe and useful for treating HIV lipodystrophy, it is not exempt from adverse effects (infection, abscesses, granulomas) that can compromise the eye area.
authors.affiliation: Servicio de Oftalmología, Complexo Hospitalario Universitario de Vigo (CHUVI), Hospital Xeral-Cíes, Vigo, España. Electronic address: brscottgarcia@gmail.com.
authors.forename: S A
authors.initials: SA
authors.lastname: García-Pacheco
authors.affiliation: Servicio de Oftalmología, Complexo Hospitalario Universitario de Vigo (CHUVI), Hospital Xeral-Cíes, Vigo, España.
authors.forename: R
authors.initials: R
authors.lastname: Blanco-Rivas
authors.affiliation: Servicio de Oftalmología, Complexo Hospitalario Universitario de Vigo (CHUVI), Hospital Xeral-Cíes, Vigo, España.
authors.forename: S
authors.initials: S
authors.lastname: Campos-García
mesh_terms: D000180:Acrylic Resins / Q000009:adverse effects*; D003357:Cosmetic Techniques / Q000009:adverse effects*; D000067548:Dermal Fillers / Q000009:adverse effects*; D005145:Face; D039682:HIV-Associated Lipodystrophy Syndrome / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D054517:Orbital Cellulitis / Q000209:etiology*
chemical_list: D000180:Acrylic Resins; C470344:Bio-Alcamid; D000067548:Dermal Fillers
keywords: Antiretroviral therapy; Celulitis preseptal; HIV; Lipodistrofia; Lipodystrophy; Polialquilamida; Polyalkylimide; Preseptal cellulitis; Terapia antirretroviral; VIH